Systematic analysis of gene expression differences between left and right atria in different mouse strains and in human atrial tissue

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Kahr, Peter C ^a,b   Piccini, Ilaria ^a   Fabritz, Larissa ^a,d   Greber, Boris ^c   Schöler, Hans ^c   Scheld, Hans H ^a   Hoffmeier, Andreas ^a   Brown, Nigel A ^b   Kirchhof, Paulus ^a,d  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR PITX2; MUSCLE PROTEIN;

ADULT; ADULT ANIMAL; AGE; AGED; ANIMAL TISSUE; ARTICLE; BMP10 GENE; CELL FUNCTION; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENOME ANALYSIS; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART RIGHT ATRIUM; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; MEMBRANE ELECTROPHYSIOLOGY; MOUSE; NONHUMAN; OPEN HEART SURGERY; PITX2C GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; GENE EXPRESSION PROFILING; GENETICS; GENOME; HEART ATRIUM; METABOLISM; VALIDATION STUDY;

ANIMALIA; MURINAE; MUS;

ANIMALS; BLOTTING, WESTERN; GENE EXPRESSION PROFILING; GENOME; HEART ATRIA; HUMANS; MICE; MUSCLE PROTEINS;

EID: 80054777216     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026389     Document Type: Article

References (41)

1. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, et al. (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98: 946-952.
2. Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, et al. (2007) Outcome parameters for trials in atrial fibrillation: executive summary: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Eur Heart J 28: 2803-2817.
3. Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, et al. (2010) Guidelines for the management of atrial fibrillation. European Heart Journal 31: 2369-2429.
4. Stewart S, Hart CL, Hole DJ, McMurray JJ, (2002) A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 113: 359-364.
5. Boyden PA, Tilley LP, Pham TD, Liu SK, Fenoglic JJ Jr, et al. (1982) Effects of left atrial enlargement on atrial transmembrane potentials and structure in dogs with mitral valve fibrosis. Am J Cardiol 49: 1896-1908.
6. Dussaule JC, Vahanian A, Michel PL, Soullier I, Czekalski S, et al. (1988) Plasma atrial natriuretic factor and cyclic GMP in mitral stenosis treated by balloon valvulotomy. Effect of atrial fibrillation. Circulation 78: 276-285.
7. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, et al. (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339: 659-666.
8. Voigt N, Trausch A, Knaut M, Matschke K, Varro A, et al. (2010) Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation. Circ Arrhythm Electrophysiol 3: 472-480.
9. Gollob MH, Jones DL, Krahn AD, Danis L, Gong XQ, et al. (2006) Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 354: 2677-2688.
10. Gudbjartsson DF, Arnar DO, Helgadottir A, Gretarsdottir S, Holm H, et al. (2007) Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 448: 353-357.
11. Kaab S, Darbar D, van Noord C, Dupuis J, Pfeufer A, et al. (2009) Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur Heart J 30: 813-819.
12. Kirchhof P, Kahr PC, Kaese S, Piccini I, Vokshi I, et al. (2011) PITX2c Is Expressed in the Adult Left Atrium, and Reducing Pitx2c Expression Promotes Atrial Fibrillation Inducibility and Complex Changes in Gene Expression. Circ Cardiovasc Genet 4: 123-133.
13. Wang J, Klysik E, Sood S, Johnson RL, Wehrens XH, et al. (2010) Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification. Proc Natl Acad Sci U S A.
14. Raya A, Izpisua Belmonte JC, (2006) Left-right asymmetry in the vertebrate embryo: from early information to higher-level integration. Nat Rev Genet 7: 283-293.
15. Campione M, Ros MA, Icardo JM, Piedra E, Christoffels VM, et al. (2001) Pitx2 expression defines a left cardiac lineage of cells: evidence for atrial and ventricular molecular isomerism in the iv/iv mice. Dev Biol 231: 252-264.
16. Liu C, Liu W, Lu MF, Brown NA, Martin JF, (2001) Regulation of left-right asymmetry by thresholds of Pitx2c activity. Development 128: 2039-2048.
17. Tessari A, Pietrobon M, Notte A, Cifelli G, Gage PJ, et al. (2008) Myocardial Pitx2 Differentially Regulates the Left Atrial Identity and Ventricular Asymmetric Remodeling Programs. Circ Res.
18. Chen H, Shi S, Acosta L, Li W, Lu J, et al. (2004) BMP10 is essential for maintaining cardiac growth during murine cardiogenesis. Development 131: 2219-2231.
19. Hang CT, Yang J, Han P, Cheng HL, Shang C, et al. (2010) Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature 466: 62-67.
20. Tabibiazar R, Wagner RA, Liao A, Quertermous T, (2003) Transcriptional profiling of the heart reveals chamber-specific gene expression patterns. Circ Res 93: 1193-1201.
21. Furtado MB, Solloway MJ, Jones VJ, Costa MW, Biben C, et al. (2008) BMP/SMAD1 signaling sets a threshold for the left/right pathway in lateral plate mesoderm and limits availability of SMAD4. Genes Dev 22: 3037-3049.
22. Jupiter DC, VanBuren V, (2008) A visual data mining tool that facilitates reconstruction of transcription regulatory networks. PLoS ONE 3: e1717.
23. Nygren A, Lomax AE, Giles WR, (2004) Heterogeneity of action potential durations in isolated mouse left and right atria recorded using voltage-sensitive dye mapping. Am J Physiol Heart Circ Physiol 287: H2634-2643.
24. Li D, Zhang L, Kneller J, Nattel S, (2001) Potential ionic mechanism for repolarization differences between canine right and left atrium. Circ Res 88: 1168-1175.
25. Sarmast F, Kolli A, Zaitsev A, Parisian K, Dhamoon AS, et al. (2003) Cholinergic atrial fibrillation: I(K,ACh) gradients determine unequal left/right atrial frequencies and rotor dynamics. Cardiovasc Res 59: 863-873.
26. Brundel BJ, Van Gelder IC, Henning RH, Tuinenburg AE, Wietses M, et al. (2001) Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels. J Am Coll Cardiol 37: 926-932.
27. Rudolph V, Andrie RP, Rudolph TK, Friedrichs K, Klinke A, et al. (2010) Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med 16: 470-474.
28. Toutouzas K, Synetos A, Drakopoulou M, Stefanadi E, Tousoulis D, et al. (2009) The role of inflammation in atrial fibrillation: a myth or a fact? Am J Med Sci 338: 494-499.
29. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, et al. (1997) Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96: 1180-1184.
30. Anne W, Willems R, Holemans P, Beckers F, Roskams T, et al. (2007) Self-terminating AF depends on electrical remodeling while persistent AF depends on additional structural changes in a rapid atrially paced sheep model. J Mol Cell Cardiol 43: 148-158.
31. Xu J, Cui G, Esmailian F, Plunkett M, Marelli D, et al. (2004) Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation 109: 363-368.
32. Motoki H, Tomita T, Aizawa K, Kasai H, Izawa A, et al. (2009) Coagulation activity is increased in the left atria of patients with paroxysmal atrial fibrillation during the non-paroxysmal period. Comparison with chronic atrial fibrillation. Circ J 73: 1403-1407.
33. Wittkopper K, Fabritz L, Neef S, Ort KR, Grefe C, et al. (2010) Constitutively active phosphatase inhibitor-1 improves cardiac contractility in young mice but is deleterious after catecholaminergic stress and with aging. J Clin Invest 120: 617-626.
34. Bruchert N, Mavila N, Boknik P, Baba HA, Fabritz L, et al. (2008) Inhibitor-2 prevents phosphatase 1 induced cardiac hypertrophy and mortality. Am J Physiol Heart Circ Physiol 295: H1539-H1546.
35. Grote-Wessels S, Baba HA, Boknik P, El-Armouche A, Fabritz L, et al. (2008) Inhibition of protein phosphatase 1 by inhibitor-2 exacerbates progression of cardiac failure in a model with pressure overload. Cardiovasc Res 79: 464-471.
36. Schwanhausser B, Busse D, Li N, Dittmar G, Schuchhardt J, et al. (2011) Global quantification of mammalian gene expression control. Nature 473: 337-342.
37. Rozen S, Skaletsky H, (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386.
38. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
39. Susan-Resiga D, Essalmani R, Hamelin J, Asselin MC, Benjannet S, et al. (2011) Furin Is the Major Processing Enzyme of the Cardiac-specific Growth Factor Bone Morphogenetic Protein 10. J Biol Chem 286: 22785-22794.
40. Saeed AI, Sharov V, White J, Li J, Liang W, et al. (2003) TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34: 374-378.
41. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.